Janux Therapeutics, Inc. (JANX) Tops Q1 EPS by 18c

Janux Therapeutics, Inc. (NASDAQ: JANX) reported Q1 EPS of ($0.39), $0.18 better than the analyst estimate of ($0.57). Revenue for the quarter came in at $3.73 million versus the consensus estimate of $4.18 million.

For earnings history and earnings-related data on Janux Therapeutics, Inc. (JANX) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Active options: AMD SNDK IREN GOOGL PLTR AVGO SOFI NKE MSTR NBIS ORCL
• China retail sales growth slows to 0.6% in July, Macquarie comments